← Back to Clinical Trials
Recruiting NCT01890486
NCT01890486 The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
◆ AI Clinical Summary
Plain-language summary for patients
| NCT ID | NCT01890486 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Wake Forest University Health Sciences |
| Condition | Acute Myelogenous Leukemia |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2001-05-21 |
| Primary Completion | 2026-12 |
Trial Parameters
Condition Acute Myelogenous Leukemia
Sponsor Wake Forest University Health Sciences
Study Type OBSERVATIONAL
Phase N/A
Enrollment 2,000
Sex ALL
Min Age 18 Years
Max Age 120 Years
Start Date 2001-05-21
Completion 2026-12
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
To provide the IRB approved mechanism for the prospective collection and analysis on participants who are undergoing either an autologous or allogeneic hematopoietic stem cell transplant for a disease in which a research question is not being addressed.
Eligibility Criteria
Inclusion Criteria: Planned standard of care dose intensive therapy and either an allogeneic or autologous bone marrow transplant Exclusion Criteria: Participation in any other treatment research protocol
Related Trials
NCT06131801
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
View Trial →
NCT06656494
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
View Trial →
NCT01890486
The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem
View Trial →
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology